Future Projections for Zytiga Use in Prostate Cancer Therapy

Projected Zytiga Treatment of Various Stages of Prostate Cancer


Early Stage

Present: LHRH agonists Zoladex, Lupron                  Future: Low dose Zytiga


Medium Stage

Present: Casodex (Bicalutamide), Ketoconazole         Future: MDV3100 (Enzalutamide), Zytiga


Advanced Stage (metastatic)

Present: Docetaxel (Taxotere)                                    Future: Docetaxel, Jevtana (Cabazitaxel)


Post Chemo

Present: Zytiga                                                           Future: Zytiga


Post Zytiga (Zytiga Refractory)

Present: Jevtana                                                         Future: Cabozantinib